CX3CR1 and Parkinson disease: Similarly, when we compared the frequencies and expression of CX3CR1 among the group of HC and PD with different disease duration, there were no significant differences in frequencies (Supplementary Fig. 1G–I) or CX3CR1 expression across NK cell subsets (Supplementary Fig. 1J–L).